News
Let's take a closer look at these three iconic dividend-paying S&P 500 stocks that you can buy at a discount, potentially ...
We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to ...
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.
Learn more about whether BioCryst Pharmaceuticals, Inc. or Halozyme Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...
Amid the ongoing uncertainty about tariffs, muted earnings season, and recession concerns, the stock market has remained ...
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...
5d
Zacks Investment Research on MSNPfizer Stock Up 5% Following Q1 Results: Time to Buy, Sell or Hold?Pfizer's PFE stock has risen 5% since it reported first-quarter results on April 29. While the company beat estimates for ...
We recently compiled a list of the 10 Most Profitable Cheap Stocks to Buy Now. In this article, we are going to take a look ...
Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...
Goldman Sachs keeps Neutral on Pfizer, citing unclear product growth plans and focus on M&A amid changing market valuations ...
10d
Benzinga on MSNPfizer Beats Q1 Profit Estimates, Expands Cost-Cutting Plan to Reach $7.7B in Savings by 2027Pfizer expanded its cost-cutting plans and posted first-quarter profit above estimates, despite a decline in sales driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results